Back 4 Good – Your future in Cork is delighted to inform subscribers that Stryker today announced that it is to invest over €200 million in Research, Development and Innovation projects at 3 of its 5 Cork facilities as it continues it vigorous innovation journey to deliver next generation products and services across its Medical, Surgical Orthopaedics and Neurotechnology and Spine offerings .
Last year Stryker invested more ethan 6% of its global sales into research and development and the R & D programme will continue positioning the company at the leading edge of advances in medical technologies of the future and consists of investment in projects at its ,
. AMagine Institute which develops additive manufacturing products for 3 divisions , Spine , Craniomaxillofacial and Joint Replacement
. Neurovascular business ,which develops stroke treatment products
. Instruments Innovation Centre ,which designs ,develops , and commercialises new and innovative surgical devices across a range of surgical procedures .
These R&D projects are world leading, highly innovative and pioneering and have the potential to change the face of healthcare provision and reaffirms Ireland as a global leader in the MedTech sector
For further information and daily updates register today on info@project.blueberry.ie
